TY - JOUR
T1 - Bridging the divide
T2 - addressing discrepancies between clinical guidelines, policy guidelines, and biomarker utilization
AU - Horgan, Denis
AU - Hofman, Paul
AU - Buttner, Reinhard
AU - Rieß, Olaf
AU - Lugowska, Iwona
AU - Dube, France
AU - Singh, Jaya
AU - Nadal, Ernest
AU - Stokłosa, Tomasz
AU - Sīviņa, Elīna
AU - Van der Buckle, Marc
AU - Mosoiu, Silvia
AU - Bertolaccini, Luca
AU - Girard, Nicolas
AU - Meerbeeck, Jan Van
AU - Omar, Imran
AU - Capoluongo, Ettore D
AU - Bielack, Stefan
AU - Hills, Tanya
AU - Baldwin, David
AU - Subbiah, Vivek
N1 - © 2024 Walter de Gruyter GmbH, Berlin/Boston.
PY - 2024
Y1 - 2024
N2 - OBJECTIVES: This paper aims to identify and address gaps in cancer treatment and diagnosis within European health services, focusing specifically on discrepancies between clinical guidelines and policy guidelines. It seeks to highlight how the underutilization of advanced diagnostic techniques recommended by medical societies contributes to missed opportunities for improving patient outcomes.METHODS: A comprehensive analysis was conducted across multiple European countries to assess the compliance and integration of clinical guidelines with the availability of advanced diagnostic technologies. Secondary data related to clinical and policy guidelines in cancer care were collected and analyzed. Key indicators of adoption and utilization of next-generation sequencing and liquid biopsy were examined to evaluate their impact on health service efficiency and patient care.RESULTS: The analysis revealed significant discrepancies between the recommendations of medical societies regarding advanced diagnostic techniques and their adoption in health policy decisions across Europe. Country-specific assessments indicated varying levels of alignment between clinical guidelines and the availability of advanced diagnostics. These findings underscored missed opportunities for optimizing patient care and health service efficiency through better alignment and integration of clinical guidelines with policy decisions.CONCLUSIONS: This study concludes that there is a critical need for health policy decision-makers to prioritize the adoption of clinical guidelines in resource allocation and health service organization. Greater attention to the recommendations of medical societies regarding advanced diagnostic techniques could significantly enhance diagnostic accuracy, treatment efficacy, and overall patient outcomes in cancer care. The paper advocates for policy reforms that acknowledge and leverage the potential benefits of advanced diagnostics in improving health service performance and patient-centered care across Europe.
AB - OBJECTIVES: This paper aims to identify and address gaps in cancer treatment and diagnosis within European health services, focusing specifically on discrepancies between clinical guidelines and policy guidelines. It seeks to highlight how the underutilization of advanced diagnostic techniques recommended by medical societies contributes to missed opportunities for improving patient outcomes.METHODS: A comprehensive analysis was conducted across multiple European countries to assess the compliance and integration of clinical guidelines with the availability of advanced diagnostic technologies. Secondary data related to clinical and policy guidelines in cancer care were collected and analyzed. Key indicators of adoption and utilization of next-generation sequencing and liquid biopsy were examined to evaluate their impact on health service efficiency and patient care.RESULTS: The analysis revealed significant discrepancies between the recommendations of medical societies regarding advanced diagnostic techniques and their adoption in health policy decisions across Europe. Country-specific assessments indicated varying levels of alignment between clinical guidelines and the availability of advanced diagnostics. These findings underscored missed opportunities for optimizing patient care and health service efficiency through better alignment and integration of clinical guidelines with policy decisions.CONCLUSIONS: This study concludes that there is a critical need for health policy decision-makers to prioritize the adoption of clinical guidelines in resource allocation and health service organization. Greater attention to the recommendations of medical societies regarding advanced diagnostic techniques could significantly enhance diagnostic accuracy, treatment efficacy, and overall patient outcomes in cancer care. The paper advocates for policy reforms that acknowledge and leverage the potential benefits of advanced diagnostics in improving health service performance and patient-centered care across Europe.
KW - clinical guidelines
KW - cancer care
KW - next-generation sequencing
KW - advanced diagnostics
KW - policy guidelines
KW - liquid biopsy
UR - https://www-webofscience-com.db.rsu.lv/wos/alldb/full-record/WOS:001281763500001
UR - http://www.scopus.com/inward/record.url?scp=85200596706&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/bad858e7-fc56-3c5b-8ac6-cb7409daf01c/
U2 - 10.1515/dx-2024-0092
DO - 10.1515/dx-2024-0092
M3 - Article
C2 - 39088796
SN - 2194-8011
JO - Diagnosis
JF - Diagnosis
ER -
